Viking Therapeutics, Inc. (VKTX)

NASDAQ: VKTX · Real-Time Price · USD

24.21

-0.19 (-0.78%)

At close: Oct 26, 2026, 4:00 PM EDT

24.32

+0.11 (0.45%)

Pre-market: Oct 27, 2026, 7:38 AM EDT

Viking Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,824	3,977	4,484	1,862	721	360
Market Cap Growth	-20.06%	-11.32%	140.89%	158.23%	100.31%	-12.38%
Enterprise Value	2,327	3,263	3,555	1,487	567	144
Last Close Price	24.21	35.18	40.24	18.61	9.40	4.60

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PB Ratio	6.92	6.22	5.09	5.34	4.96	1.78
P/TBV Ratio	6.92	6.22	5.09	5.34	4.96	1.78

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.01	0	0.00	0.00	0.01	0
Net Debt / Equity Ratio	-1.22	-1.10	-1.02	-1.04	-1.06	-1.00
Quick Ratio	4.58	9.21	32.93	18.92	7.09	23.02
Current Ratio	4.72	9.33	33.09	19.19	7.61	23.98
Return on Equity (ROE)	-88.85%	-47.34%	-17.90%	-34.79%	-39.67%	-24.65%
Return on Assets (ROA)	-51.86%	-30.28%	-14.77%	-23.47%	-23.19%	-14.90%
Return on Capital Employed (ROCE)	-135.80%	-61.50%	-17.10%	-28.90%	-48.00%	-27.60%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-19.28%	-9.04%	-2.45%	-4.61%	-9.55%	-15.28%
Buyback Yield / Dilution	-2.64%	-3.33%	-15.57%	-22.79%	0.47%	-6.34%

SEC Filings: 10-K · 10-Q